Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Dapril 5 mg tablets.
Dapril 10 mg tablets.
Dapril 20 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Dapril 5 mg tablets are uncoated, peach, round, and convex. Dapril 10 mg tablets are uncoated, peach, round, and convex. Dapril 20 mg tablets are uncoated, peach, round, and convex. |
Each Dapril 5 mg tablet contains lisinopril dihydrate equivalent to 5 mg anhydrous lisinopril.
Each Dapril 10 mg tablet contains lisinopril dihydrate equivalent to 10 mg anhydrous lisinopril.
Each Dapril 20 mg tablet contains lisinopril dihydrate equivalent to 20 mg anhydrous lisinopril.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Lisinopril |
Lisinopril is a peptidyl dipeptidase inhibitor. It inhibits the angiotensin-converting enzyme (ACE) that catalyses the conversion of angiotensin I to the vasoconstrictor peptide, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. Inhibition of ACE results in decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion. |
| List of Excipients |
|---|
|
Dapril tablets 5 mg, 10 mg, and 20 mg also contain mannitol (E421), dicalcium phosphate dihydrate, red iron oxide (E172), maize starch, pregelatinised maize starch, and magnesium stearate. |
PVC/PVDC-Aluminium blisters of ten tablets. Packs of ten (all strengths), thirty tablets (all stregths) and twenty tablets (20 mg), with a patient information leaflet are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Dapril 5 mg: 13083
Dapril 10 mg: 13084
Dapril 20 mg: 13085
Dapril 5m g: 26/11/1990
Dapril 10 mg: 26/11/1990
Dapril 20 mg: 26/11/1990
| Drug | Countries | |
|---|---|---|
| DAPRIL | Cyprus, Hong Kong, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
